By Maggie Fick and Jacob Gronholt-Pedersen LONDON/COPENHAGEN (Reuters) -Novo Nordisk's shares fell nearly 5% on Friday after ...

EMA endorses Novo Nordisk's Wegovy for treating heart failure and lowering heart risks in obese patients. Second approval ...

Research has shown there are plenty of perks of using a medication like Ozempic for weight loss. But, given that this is a ...

Semaglutide injections effectively support weight loss by regulating appetite and glucose levels, offering benefits for ...

The new Lemme GLP-1 Daily Capsules are being called an "Ozempic alternative." But do they really work — and if so, at what ...

Weight-loss drugs like Ozempic are booming in popularity, but experts warn they aren't silver bullets for obesity.

Eli Lilly's valuation is a critical concern, but its robust execution has improved its ability to actualize its high-growth ...

The products are being advertised as more affordable alternatives to blockbuster weight-loss drugs. Here’s what doctors think ...

The line includes thoughtfully portioned meals that offer at least 20 grams of protein and contain essential nutrients such ...

In this morning’s readout from Novo's phase 2 trial of monlunabant in 243 people with obesity and metabolic syndrome, it ...

While both berberine and Ozempic may lead to weight loss, they are very different things. It’s “inaccurate and misleading” to ...

A next-generation obesity drug candidate from Novo Nordisk produced modest weight loss, along with a higher rate of some ...